EX-2 3 f13d042712_ex2.htm EX 2 WAIVER AGREEMENT WAIVER AGREEMENTWaiver Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionThis Waiver Agreement (the “Waiver Agreement”) is entered into as of this 25th of January 2012 by and between Transdel Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and DermaStar International, LLC, a Nevada limited liability company (“DermaStar” and also the “Holder”).
WAIVER AGREEMENTWaiver Agreement • May 10th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 10th, 2012 Company Industry JurisdictionThis Waiver Agreement (the “Waiver Agreement”) is entered into as of this 17th of January 2012 by and between Transdel Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and DermaStar International, LLC, a Nevada limited liability company (“DermaStar” and also the “Holder”).
WAIVER AGREEMENTWaiver Agreement • May 10th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 10th, 2012 Company Industry JurisdictionThis Waiver Agreement (the “Waiver Agreement”) is entered into as of this 18th of January 2012 by and between Transdel Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Alexej Ladonnikov, an individual (the “Holder”).
WAIVER AGREEMENTWaiver Agreement • April 30th, 2012 • Dermastar International, LLC • Pharmaceutical preparations • California
Contract Type FiledApril 30th, 2012 Company Industry JurisdictionThis Waiver Agreement (the “Waiver Agreement”) is entered into as of this 25th of January 2012 by and between Transdel Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and DermaStar International, LLC, a Nevada limited liability company (“DermaStar” and also the “Holder”).